Bioavailability of bismuth from205Bi-labelled pharmaceutical oral Bi-preparations in rats
| Autor: | Peter E. Nielsen, Jürgen Wendel, Roland Fischer, Erich E. Gabbe, Hellmuth C. Heinrich, Bernd Dresow |
|---|---|
| Rok vydání: | 1991 |
| Předmět: |
inorganic chemicals
Health Toxicology and Mutagenesis Administration Oral Biological Availability chemistry.chemical_element Pharmacology Toxicology digestive system Dosage form Intestinal absorption Bismuth Pharmacokinetics Oral administration Animals Tissue Distribution Antibacterial agent Radioisotopes Chromatography Chemistry Rats Inbred Strains General Medicine bacterial infections and mycoses equipment and supplies digestive system diseases Rats Bioavailability Intestinal Absorption Solubility Female Biological half-life Half-Life |
| Zdroj: | Archives of Toxicology. 65:646-650 |
| ISSN: | 1432-0738 0340-5761 |
| DOI: | 10.1007/bf02098030 |
| Popis: | The bioavailability of 205Bi from various 205Bi-labelled pharmaceutical oral bismuth preparations was studied in rats. The intestinal absorption, calculated from 205Bi whole body retention and accumulated 205Bi urinary excretion, was small in general, but significantly higher (0.26-0.33% of dose) from oral bismuth citrates (basic bismuth citrate, colloidal bismuth subcitrate) as compared to basic bismuth nitrate, salicylate, gallate, and bismuth aluminate (0.04-0.11% of dose). After oral administration, the retained bismuth was mainly accumulated in the kidney, followed by bone, red blood cells and the lung. The whole body retention, faecal and urinary excretions of 205Bi were described by a three-compartment model. Biological 205Bi half-lives of 10, 36 and 295 h were derived in rats. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink